ETON · Eton Pharmaceuticals Inc
United States · RS rating 94 · As of 2026-10-14
| Price | 52.88 USD |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 94 / 42 / 95 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 51 / 59 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +171.4% |
| Sales growth Q/Q | -5.2% |
| Distance from 52-week high | +17.9% |
| Market cap (USD) | $626.7M |